Endometrial thickness in tamoxifen-treated patients: an independent predictor of endometrial disease.

@article{Franchi1999EndometrialTI,
  title={Endometrial thickness in tamoxifen-treated patients: an independent predictor of endometrial disease.},
  author={Massimo Franchi and Fabio Ghezzi and Nicoletta Donadello and Flavia Zanaboni and Paolo Beretta and Pierfrancesco Bolis},
  journal={Obstetrics and gynecology},
  year={1999},
  volume={93 6},
  pages={1004-8}
}
OBJECTIVE To assess the independent contribution of transvaginal ultrasound in identifying women at risk for endometrial disorders, and determine whether a cutoff value identifies women who need endometrial histologic assessment. METHODS Postmenopausal women with breast cancer who were receiving tamoxifen, with ultrasonographic endometrial thickness greater than 4 mm or vaginal bleeding, had hysteroscopy with selective endometrial biopsies. Endometrial thickness, duration of tamoxifen therapy… CONTINUE READING